SIGA Technologies, Inc.
Support and Resistance Levels
Past performance
News About SIGA
All events for SIGA
All deals for SIGA
Financial Ratios
Financial Statements
SIGA vs Sector & Peers
About SIGA Technologies, Inc.
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York. Website siga.com
Headquarters New York City, NY, US